Checkpoint Capital L.P.
- SEC CIK
- 0001977548
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 17
- 0 vs. Q4 2023
- Portfolio value
- $149.6M
- +$6.32M (+4.4%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | COM | 825,500 | $35.8M | 23.9% | +95,500+13.1% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 82,000 | $32.3M | 21.6% | +12,000+17.1% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 190,000 | $13.3M | 8.9% | −40,000−17.4% | Reduced | History |
| AVDLAvadel Pharmaceuticals PLC | SPONSORED ADR | 701,387 | $11.8M | 7.9% | +376,387+115.8% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 132,437 | $10.6M | 7.1% | −22,909−14.7% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 362,193 | $9.10M | 6.1% | +128,534+55.0% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 280,301 | $8.11M | 5.4% | +13,445+5.0% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 273,776 | $6.90M | 4.6% | +273,776 | New | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 618,528 | $5.39M | 3.6% | −261,472−29.7% | Reduced | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 445,161 | $4.73M | 3.2% | +85,715+23.8% | Added | History |
| ATYRaTYR PHARMA INC | COM NEW | 1,446,477 | $2.82M | 1.9% | −57,077−3.8% | Reduced | History |
| VSTMVerastem, Inc. | COM NEW | 168,739 | $1.99M | 1.3% | +168,739 | New | History |
| GHRSGH Research PLC | ORDINARY SHARES | 185,653 | $1.98M | 1.3% | −108,292−36.8% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 506,082 | $1.75M | 1.2% | −786,234−60.8% | Reduced | History |
| APLTApplied Therapeutics, Inc. | COM | 220,000 | $1.50M | 1.0% | +220,000 | New | History |
| ALLKAllakos Inc. | COM | 767,964 | $967.6K | 0.6% | +323,160+72.7% | Added | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 892,853 | $619.6K | 0.4% | +892,853 | New | History |
Sold out since Q4 2023 (4)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 340,000 | $12.4M | 8.7% | History |
| IRONDisc Medicine, Inc. | COM | 10,000 | $577.6K | 0.4% | History |
| ACRSAclaris Therapeutics, Inc. | COM | 453,614 | $476.3K | 0.3% | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 33,000 | $361.0K | 0.3% | History |